Not Yet RecruitingNot Applicable

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

30 participantsStarted 2026-05-30

Plain-language summary

This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days).
✓. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
✓. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.

Exclusion criteria

✕. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days).
✕. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
✕. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.

What they're measuring

RV vs LV end-diastolic diameter ratio

Timeframe: after the completion of EKOS treatment 48 hours compared with the baseline

Trial details

NCT IDNCT06819865

SponsorBoston Scientific Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-03-30

Contact for this trial

Yue

010-85216440 Taimin.yue@bsci.com

View on ClinicalTrials.gov More Acute Pulmonary Embolism trials